🇺🇸 FDA
Pipeline program

Azvudine

SWYX2023022

Approved small_molecule active

Quick answer

Azvudine for COVID-19 is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
COVID-19
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials